Asahi Life Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $527K | Buy |
21,868
+289
| +1% | +$7.56K | 0.3% | 69 |
|
|
2026
Q1 | $606K | Sell |
21,579
-3,364
| -13% | -$89.6K | 0.39% | 51 |
|
|
2025
Q4 | $621K | Hold |
24,943
| – | – | 0.35% | 58 |
|
|
2025
Q3 | $636K | Buy |
+24,943
| New | +$616K | 0.35% | 53 |
|
|
2025
Q2 | – | Sell |
-10,850
| Closed | -$275K | – | 193 |
|
|
2025
Q1 | $275K | Sell |
10,850
-720
| -6% | -$18.8K | 0.18% | 152 |
|
|
2024
Q4 | $307K | Sell |
11,570
-11,080
| -49% | -$301K | 0.19% | 140 |
|
|
2024
Q3 | $655K | Buy |
22,650
+2,340
| +12% | +$68.3K | 0.4% | 48 |
|
|
2024
Q2 | $568K | Sell |
20,310
-2,060
| -9% | -$56.7K | 0.39% | 50 |
|
|
2024
Q1 | $621K | Buy |
+22,370
| New | +$621K | 0.37% | 46 |
|
|
2023
Q4 | – | Sell |
-20,230
| Closed | -$671K | – | 221 |
|
|
2023
Q3 | $671K | Buy |
20,230
+1,260
| +7% | +$44.6K | 0.23% | 51 |
|
|
2023
Q2 | $696K | Sell |
18,970
-760
| -4% | -$29.6K | 0.23% | 52 |
|
|
2023
Q1 | $805K | Sell |
19,730
-300
| -1% | -$13K | 0.26% | 50 |
|
|
2022
Q4 | $1.03M | Buy |
20,030
+490
| +3% | +$23.5K | 0.34% | 46 |
|
|
2022
Q3 | $855K | Buy |
19,540
+360
| +2% | +$17.5K | 0.26% | 45 |
|
|
2022
Q2 | $1.01M | Buy |
19,180
+11,120
| +138% | +$567K | 0.27% | 45 |
|
|
2022
Q1 | $417K | Buy |
8,060
+300
| +4% | +$15.6K | 0.06% | 118 |
|
|
2021
Q4 | $458K | Sell |
7,760
-50
| -0.6% | -$2.48K | 0.06% | 105 |
|
|
2021
Q3 | $336K | Sell |
7,810
-12,260
| -61% | -$543K | 0.05% | 132 |
|
|
2021
Q2 | $786K | Buy |
20,070
+2,760
| +16% | +$107K | 0.11% | 52 |
|
|
2021
Q1 | $627K | Sell |
17,310
-10,870
| -39% | -$386K | 0.09% | 65 |
|
|
2020
Q4 | $1.04M | Sell |
28,180
-152
| -0.5% | -$5.58K | 0.13% | 58 |
|
|
2020
Q3 | $986K | Sell |
28,332
-127,972
| -82% | -$4.49M | 0.15% | 43 |
|
|
2020
Q2 | $4.85M | Sell |
156,304
-15,312
| -9% | -$520K | 0.8% | 33 |
|
|
2020
Q1 | $5.32M | Buy |
171,616
+11,025
| +7% | +$376K | 0.95% | 32 |
|
|
2019
Q4 | $5.97M | Buy |
160,591
+10,915
| +7% | +$389K | 0.88% | 32 |
|
|
2019
Q3 | $5.1M | Buy |
149,676
+36,566
| +32% | +$1.33M | 0.83% | 33 |
|
|
2019
Q2 | $4.65M | Sell |
113,110
-36,042
| -24% | -$1.43M | 0.93% | 33 |
|
|
2019
Q1 | $6.01M | Sell |
149,152
-28,947
| -16% | -$1.16M | 0.98% | 30 |
|
|
2018
Q4 | $7.38M | Buy |
+178,099
| New | +$7.39M | 1.15% | 29 |
|
Other funds holding PFE
Asahi Life Asset Management's PFE Position: Q2 2026 in Review
Asahi Life Asset Management increased its Pfizer (PFE) stake by 1.3% in Q2 2026, buying an estimated $7.56K and bringing the position to 21,868 shares worth $527K. The position accounts for 0.3% of the portfolio, ranked #69.
Asahi Life Asset Management first reported a position in PFE in Q4 2018 and has held it in 29 quarters since. The position peaked at $7.38M in Q4 2018. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Asahi Life Asset Management held 21,868 shares of Pfizer worth $527K as of Q2 2026.
- Asahi Life Asset Management bought 289 Pfizer shares in Q2 2026, an estimated $7.56K.
- Pfizer made up 0.3% of Asahi Life Asset Management's portfolio in Q2 2026, its #69 holding.
- Asahi Life Asset Management first reported a position in Pfizer in Q4 2018 and has held it in 29 quarters since.
- Asahi Life Asset Management's Pfizer position peaked at $7.38M in Q4 2018.
- 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Asahi Life Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.